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ORIGINAL SUBMISSIONSVascular Thoracic Outlet Syndrome
Mohamad Anas Hussain, MD,*,† Badr Aljabri, MD, FRCSC,‡,§ and Mohammed Al-Omran, MD,
MSc, FRCSC*,†,‡,§Arterial TOS: subclavian artery compression in the
scalene triangle by a cervical rib.
Central Message
The approach to vascular TOS has undergone
signiﬁcant evolution given the emergence of
endovascular therapies over the last decade.Two distinct terms are used to describe vascular thoracic outlet syndrome
(TOS) depending on which structure is predominantly affected: venous TOS
(due to subclavian vein compression) and arterial TOS (due to subclavian
artery compression). Although the venous and arterial subtypes of TOS affect
only 3% and o1% of all TOS patients respectively, the diagnostic and
management approaches to venous and arterial TOS have undergone
considerable evolution due to the recent emergence of minimally invasive
endovascular techniques such as catheter-directed arterial and venous
thrombolysis, and balloon angioplasty. In this review, we discuss the
anatomical factors, etiology, pathogenesis and clinical presentation of
vascular TOS patients. In addition, we use the most up to date observational
evidence available to provide a contemporary approach to the diagnosis and
management of venous TOS and arterial TOS patients.
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be divided into 2 forms (arterial and venous)
depending on which structure is compressed in
the thoracic outlet. Clinical evidence for vas-
cular TOS is limited to case series, with a
paucity of randomized controlled trials. Our
review focuses on the contemporary diagnostic
and management approach to vascular TOS
given the increased popularity of endovascular
techniques.
See Editorial Commentary page 158–159.OVERVIEW
TOS refers to a constellation of signs and symptoms
attributable to compression of the neurovascular bundle in
the thoracic outlet region of the upper extremity. A total of 3
distinct terms are used to describe TOS depending on which
structure is predominantly affected: neurogenic TOS (nTOS)
from brachial plexus compression, venous TOS (vTOS) from
subclavian vein compression, and arterial TOS (aTOS) from
subclavian artery compression. The most common form by far
is nTOS, which accounts for more than 90% of all TOS cases.
This review focuses on the venous and arterial subtypes of TOS,
which are seen in 3% ando1% of TOS patients, respectively.
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The borders of the anterior scalene muscle, middle scalene
muscle, and ﬁrst rib deﬁne the scalene triangle; trunks of the
brachial plexus and the subclavian artery pass through this
space (Fig. 1A). Cervical ribs and anomalous ﬁrst ribs may
compress the scalene triangle, resulting in symptoms of nTOS
or aTOS. The costoclavicular space, which is the area between
the ﬁrst rib and the clavicle housing all 3 major structures
(subclavian artery, vein, and brachial plexus), represents the
most common site of subclavian vein compression (Fig. 1B).
The PM space, deﬁned by the PM muscle anteriorly and the
chest wall posteriorly, is an extension of the thoracic outlet and
a common site of neurovascular compression.
ETIOLOGY
Most patients with TOS are adults between the age of 20 and
50 years, although adolescents aged 18 years or younger
present with vascular TOS more frequently than adults.1ved. 151
Figure 1. Illustration of the thoracic outlet showing the 3 common sites of vascular compression: scalene
triangle, costoclavicular space, and pectoralis minor space. The subclavian artery is most commonly
compressed in the scalene triangle with the presence of an accessory cervical rib, leading to arterial TOS (A).
Venous TOS commonly occurs due to compression of the subclavian vein in the costoclavicular space
between the costoclavicular ligament, ﬁrst rib and subclavius tendon (B). (Adapted with permission from
Oomen et al.)
VASCULAR THORACIC OUTLET SYNDROMEFactors that increase the risk of neurovascular
compression and development of symptomatic
TOS include congenital anomalies in the thoracic
outlet, repetitive motion or stress activities, and
traumatic injuries. Arterial TOS is associated with
bone abnormalities or trauma in nearly all cases,
whereas vTOS is most often the result of repetitive
overhead arm and shoulder activities, such as swim-
ming, throwing, or weight-lifting in combination
with anomalies of the costoclavicular space.
PATHOGENESIS
Arterial TOS is most commonly associated with
bone abnormalities of the thoracic outlet, with
cervical ribs being present in up to 85% of patients
with aTOS in contemporary series.2-5 Cervical ribs
are present in o1% of the general population, and
about 70% of individuals with cervical ribs are
women. Cervical ribs that cause symptoms are often
large, and can have bony fusion to the ﬁrst rib that
results in subclavian artery compression.6 This
causes injury to the third segment of the subclavian
artery, leading to intimal damage, thrombosis, distal
embolism or poststenotic dilation, and aneurysm
formation. Rarely, complete occlusion of the sub-
clavian artery may occur. Other less common
anatomic abnormalities causing aTOS include anom-
alous ﬁrst rib, prominent C7 transverse process,
callus formation from an old clavicular or ﬁrst rib
fracture, and ﬁbrocartilaginous band.
In vTOS, the subclavian vein is often compressed
between the ﬁrst rib, costoclavicular ligament and152 Seminsubclavius tendon within the costoclavicular space
(Fig. 1B). Repetitive arm movements traumatize the
vein, causing posttraumatic inﬂammation, focal
intimal ﬁbrosis, stenosis, blood ﬂow stasis, and
eventual thrombosis leading to acute symptoms of
upper extremity deep venous thrombosis. This
clinical condition is referred to as effort thrombosis
or Paget-Schroetter syndrome, and is often observed
in young individuals and competitive athletes who
engage in physical activities requiring repetitive arm
and shoulder movements.7 Chronic compression
and repetitive trauma also cause inﬂammation exter-
nal to the subclavian vein. This point is underscored
by the ﬁbrotic, hypertrophied and relatively ﬁxed
surrounding anatomic structures often observed
during vTOS surgery.
CLINICAL PRESENTATION
Early in the disease process, aTOS patients most
commonly present with chronic arm, shoulder, or
neck pain with increasing activity due to subclavian
artery stenosis or thrombosis. Hand or arm ischemia
due to arterial embolization is the most common
acute presentation of aTOS. A subset of aTOS
patients present with concomitant symptoms of
nTOS, such as chronic arm or hand paresthesias,
numbness, or weakness from coexisting brachial
nerve compression.8 Physical examination for aTOS
focuses on measuring bilateral blood pressures of the
upper extremities to asses for a marked discrepancy
between the symptomatic and asymptomatic side,
palpating for cervical ribs or a pulsatile mass in thears in Thoracic and Cardiovascular Surgery  Volume 28, Number 1
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digital ischemia, and auscultating for bruits in the
supraclavicular fossa. Moreover, narrowing the
artery through shoulder abduction may provoke
bruits if not present at rest.
The classic clinical ﬁnding of vTOS is upper
extremity edema with dilated subcutaneous collat-
eral veins evident over the arm, shoulder, and chest
wall. These collateral veins develop to accommodate
the increased venous pressure from subclavian vein
stenosis or thrombosis. In the largest series of vTOS
to date (626 extremities), Urschel and Patel9 reported
that vTOS patients most commonly present with
visible collateral veins around the shoulder (99%),
followed by arm swelling (96%), bluish discoloration
(94%), aching pain with exercise (33%), and cervical
ribs (10%). Only 4% of the patients presented with
minimal symptoms. Severe complications of acute
deep venous thrombosis, such as pulmonary embo-
lism or venous gangrene, are rare.
DIAGNOSIS
Plain radiography of the neck and chest with
cervical spine view or thoracic inlet view will often
demonstrate bone abnormalities that may aid in the
diagnosis of TOS. Cervical ribs, prominent, or
elongated C7 transverse processes, abnormal or
elongated ﬁrst ribs, and large fracture calluses are
easily detected on plain radiographs. In a study of 31
patients with TOS, only 2 had normal plain radio-
graphs, whereas the other 29 had abnormalities,
such as cervical ribs and enlarged transverse proc-
esses detectable on plain radiographs.10 However,
the negative predictive value of plain radiography is
debatable, and more deﬁnitive diagnostic imaging is
required in nearly all cases to establish or exclude a
diagnosis of TOS.
Duplex ultrasound (DUS) examination is an
effective initial approach in conﬁrming clinicalFigure 2. Duplex arterial ultrasound with waveforms of a 2
the left subclavian artery at rest (A), and complete cessa
shoulder (B).
ic and Cardiovascular Surgery  Volume 28, Numbesuspicion of vascular TOS. Aneurysmal change,
arterial stenosis, and thrombosis can be detected by
DUS of the subclavian and axillary arteries. More-
over, DUS has the advantage of assessing dynamic
blood ﬂow during compression maneuvers (hyper-
abduction), with a decrease in arterial diameter,
changes in peak velocity or reproducible symptoms
considered to be diagnostic of aTOS. Figure 2 shows
an arterial DUS of the upper extremity with normal
ﬂow in the left brachial artery at rest, and complete
cessation of ﬂow with 451 of arm abduction above
the shoulder—a classic ﬁnding in aTOS. DUS also
has good accuracy in detecting subclavian-axillary
vein thrombosis, although its use is limited in
providing information about surrounding structures
or preoperative planning.
Conventional catheter-based arteriography or
venography has traditionally been considered the
gold standard diagnostic test for vascular TOS as it
provides information about the exact location and
nature of the vascular compression. However,
because of its invasive nature, and lack of visual-
ization of surrounding structures means catheter-
based angiography and venography are largely
reserved for intraprocedural interventional guidance.
Contrast-enhanced computed tomography (CT)
and magnetic resonance (MR) are now widely
available, reliable, and reproducible modalities used
to establish the diagnosis of vascular TOS. CT and
MR are typically performed as 2-step procedures
(neutral position and arm abduction) to reproduce
the vascular compression seen on provocative
maneuvers. CT angiography or venography provides
superior analysis of the vasculature in relation to the
bony structures, whereas MR angiography or venog-
raphy is more efﬁcient in the depiction of accessory
muscles, muscle hypertrophy and ﬁbrous bands.11
Both of these imaging modalities are useful in
delineating the exact location and nature of the1-year-old patient with aTOS showing normal ﬂow in
tion of ﬂow with arm abduction 45 degrees above the
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Figure 3. CT angiogram with 3-dimensional reconstruction of the neck and chest showing bilateral cervical
ribs (arrowheads), severe stenosis of the left subclavian artery with poststenotic dilatation (solid arrow), and
occlusion of the left brachial artery distally (dashed arrow) in a patients with aTOS.
VASCULAR THORACIC OUTLET SYNDROMEvascular compression, and aid in surgical planning.
The American College of Radiology Appropriateness
Criteria recommendations suggest that CT and MR
angiography or venography are both appropriate in
establishing the diagnosis of TOS12; therefore, which
imaging modality is selected likely depends on
clinician and institutional experience and expertise.
Figure 3 presents a CT angiogram showing moderate
impingement of the left subclavian artery by a
cervical rib with poststenoic dilatation, and distal
embolization to the left brachial artery in a patient
with an acute ischemic arm secondary to aTOS.MANAGEMENT
Arterial TOS
The management strategy for aTOS is guided by
the nature and severity of arterial complications.
Asymptomatic patients with subclavian artery com-
pression without evidence of arterial degeneration
may be managed nonsurgically due to a low risk of
complications. It is reasonable to follow these patients
with serial imaging of the arterial system, as the
natural history of these patients is not clearly deﬁned.
We prefer to perform arterial DUS of the upper
extremity every 6 months in these patients, although
it is unclear if this practice leads to earlier diagnosis of
arterial complications. Surgical treatment is required
for patients with symptoms and evidence of arterial
complications, such as intimal damage, mural throm-
bus, embolization, poststenotic dilatation, or aneur-
ysm formation. The appropriate surgical strategy is
guided by 3 main principles: decompression, arterial
resection, and distal revascularization.1.15Decompression: At minimum, relieving the arterial
compression involves resection of cervical or ﬁrst
ribs, ﬁbrous bands, scalenectomy, and removing
any other associated anomalies. Some authors
suggest that the ﬁrst rib should be routinely4 Seminarremoved to prevent recurrence of symptoms
because it acts as a key insertion point for
ﬁbromuscular bands that cause vascular com-
pression.13 Others argue that anterior and middle
scalenectomy alone is as effective as scalenectomy
with ﬁrst rib resection, and that a rib-sparing
approach leads to less morbidity, including a
lower risk of pleural or plexus injury and shorter
hospital stay.14,15 However, the evidence for this
is limited, and largely focused on patients with a
past history of neurogenic TOS. Consequently,
for now, one approach cannot be recommended
over another.2. Arterial resection: Resection of any potential
source of arterial embolus such as a subclavian
artery aneurysm or luminal stenosis with intimal
damage is necessary to prevent ischemic compli-
cations of the upper extremity.3. Distal revascularization: Vascular reconstruction
in the form of primary anastomosis, interposition
graft, or axillary-brachial bypass may be required
depending on the extent of the subclavian artery
resection. If evidence of distal embolus is present,
intraarterial thrombolysis or thromboembolec-
tomy may be used in conjunction with arterial
reconstruction to improve outﬂow of the limb.
There are 2 main surgical approaches to thoracic
outlet decompression: transaxillary and supraclavic-
ular. The primary advantage of the transaxillary
approach is that it provides complete visualization
of the ﬁrst rib for removal, and poses minimal risk to
critical neurovascular structures that are distant from
the ﬁrst rib.16 However, this approach is largely used
for nTOS, as it is not suitable for vascular recon-
struction. The supraclavicular approach is preferable
for aTOS as it allows resection of the cervical and
ﬁrst ribs, ﬁbromuscular structures, and vascular
reconstruction. However, care must be taken to
identify and protect the brachial plexus and others in Thoracic and Cardiovascular Surgery  Volume 28, Number 1
Figure 4. Supraclavicular exposure of the thoracic
outlet with divided scalenus anterior and medial
muscles. SA, subclavian artery; BP, brachial plexus;
LP, lung pleura; PN, phrenic nerve; LTN, long
thoracic nerve.
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Seminars in Thoracneurovascular structures, such as the phrenic and
long thoracic nerves, and the subclavian vein with
this approach. The supraclavicular exposure of the
thoracic outlet is illustrated in Figure 4.
Contemporary series report negligible operative
mortality and a complete resolution of aTOS symp-
toms in490% of patients.2-5 One of the largest and
most recent series, which examined 49 cases of aTOS,
showed that operative morbidity in this population is
low (13%), and mainly related to transient nerve
injury to the brachial plexus that resolves completely
with conservative management.2 Other potential
complications include arterial rethrombosis, hemo-
thorax, pneumothorax, or chylous leak.
Although open surgical revascularization is consid-
ered the gold standard approach to aTOS, some case
studies have described endovascular stenting of the
subclavian artery in combination with surgical
decompression.17,18 The advantage of this hybrid
technique is a less invasive approach to subclavian
artery revascularization; however, this must be
weighed against a higher risk of stent fracture at this
location due to compression from external structures
such as the clavicle and ﬁrst rib.19 More long-term
data is needed before subclavian artery stenting can be
considered a valid alternative to surgical revasculari-
zation. Intraarterial thrombolysis for a distal embolus
or thrombus is another treatment option, particularly
if the upper limb is acutely threatened from severe
ischemia. Thrombolysis must be followed by thoracicic and Cardiovascular Surgery  Volume 28, Numbeoutlet decompression and arterial repair to remove the
source of embolus such as subclavian artery stenosis
or aneurysm. Regardless of which arterial revascula-
rization technique is selected, surgical decompression
is fundamental to thoracic outlet treatment.Venous TOS
The natural history of acute primary subclavian-
axillary vein thrombosis is associated with high long-
term morbidity and disability. Furthermore, historical
series have reported persistent or recurrent symptoms
in470% of vTOS patients treated with anticoagulation
alone.9 Therefore, treatment for vTOS involves consid-
eration of 3 therapies in addition to anticoagulation:
thrombolysis, decompression, and venoplasty. Which
therapy is selected depends on the clinical presentation
of patients with vTOS. Several contemporary series
have suggested various treatment algorithms for vTOS
based on their local experience.5,9,20-29 Taken as a
whole, the approach to vTOS management can be
summarized based on 3 patient presentations (Fig. 5).1.r 1Acute: For patients presenting acutely (o6 weeks
since symptom onset), prompt catheter-directed
thrombolysis with early surgical decompression
of the thoracic outlet has been reported to
produce 490% clinical success. A short course
of anticoagulation may be required until venous
patency is conﬁrmed by postoperative imaging.
Venoplasty of a residual subclavian vein stenosis
after decompression may be considered to reduce
the risk of rethrombosis.2. Chronic: Patients presenting with chronic (Z6
weeks) stenosis or occlusion of the subclavian
vein with evidence of vTOS beneﬁt from surgical
decompression. Preoperative thrombolysis may
be considered in patients with total occlusion in
an attempt to restore luminal patency before
decompression. A course of postoperative anti-
coagulation may be required until venous patency
is conﬁrmed by postoperative imaging. Veno-
plasty of a residual subclavian vein stenosis may
be considered to reduce the risk of rethrombosis.3. Intermittent obstruction: Patients with chronic
symptoms of intermittent venous obstruction
but without evidence of thrombus or signiﬁcant
stenosis require only surgical decompression.
Thrombolysis, anticoagulation, or venoplasty are
generally not required.
Infraclavicular, paraclavicular, and transaxillary
approaches have all been well described for subclavian
vein decompression. Which approach is selected
often depends on operator experience and preference,
as there is insufﬁcient evidence to recommend one155
Figure 5. Treatment approach to venous TOS based on clinical presentation.
VASCULAR THORACIC OUTLET SYNDROMEapproach over another. Operative principles are
similar to aTOS—ﬁrst rib resection with scalenectomy
to decompress the thoracic outlet, and venolysis.
Given the most common site of venous compression
is in the costoclavicular space, ﬁrst rib resection is
generally preformed routinely in vTOS patients in
combination with scalenectomy. Furthermore, rou-
tine ﬁrst rib resection has been associated with
improved quality of life in patients with vTOS.30
A few studies have examined the role of venous
angioplasty and stenting before decompressing the
thoracic outlet, with suboptimal results. Venous
stenting in a nondecompressed costoclavicular junc-
tion is associated with high rates of stent fracture and
rethrombosis,29,31 likely due to external compres-
sion of the stent by the unyielding structures of the
thoracic outlet. Therefore, primary stenting of the
subclavian vein without thoracic outlet decompres-
sion is not indicated.
Residual stenosis of the subclavian-axillary vein is
not uncommon following decompression due to
ﬁbrous strictures or thrombus; options for manage-
ment include intraoperative or postoperative venog-
raphy and angioplasty with or without stent
insertion, vein patching, mechanical thrombectomy,
or axillary-subclavian vein reconstruction. Although
no study has directly compared outcomes between156 Seminthese different approaches, most authors prefer to
perform venoplasty at the time of decompression or
within 1-2 weeks postoperatively of any residual
stenosis because of its minimally invasive nature and
excellent reported 1-year primary and secondary
patency rates of 92% and 96%.25 Venous DUS is
an efﬁcient noninvasive imaging modality for routine
postoperative surveillance, although a venogram
may be preformed at the ﬁrst postoperative visit if
residual venous stenosis is suspected and venoplasty
is considered. With respect to anticoagulation, a
short course of 3-6 months may be required if there
is residual thrombus on postoperative imaging.
Venous TOS series have generally only reported
warfarin as the anticoagulation agent of choice,
although alternative agents such as oral factor Xa
inhibitors may be considered given their efﬁcacy in
the treatment of venous thrombosis.32,33
CONCLUSION
Although uncommon, vascular TOS presents
diagnostic and management challenges to the
modern cardiovascular surgeon. Clinical evi-
dence for the approach to vascular TOS is limited
to case series, with a paucity of randomized
controlled trials and prospective data. However,
over the past decade, the continual emergence ofars in Thoracic and Cardiovascular Surgery  Volume 28, Number 1
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Seminars in Thoractechnological leaps in the form of endovascular
techniques such as catheter-directed arterial and
venous thrombolysis, and balloon angioplasty hasic and Cardiovascular Surgery  Volume 28, Numbeconsiderably diversiﬁed the contemporary approach
to vascular TOS. Further research is needed to deﬁne
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